1. EMA recommends restrictions on Multaq use

   Media release 18 January 2013 Pages: 1 - 1

2. FDA continues review of drospirenone-containing OCs

   News item 18 January 2013 Pages: 2 - 2

3. Trasylol suspension lifted in Canada

   Media release 18 January 2013 Pages: 2 - 2

4. EMA reviews risk of severe liver injury with orlistat

   Media release 18 January 2013 Pages: 2 - 2

5. Off-label Avastin use under investigation

   News item 18 January 2013 Pages: 3 - 3

6. Bimatoprost side effect has cosmetic appeal

   News item 18 January 2013 Pages: 3 - 3

7. The EMA's CHMP recommends the permanent discontinuation of lacosamide [Vimpat] 15 mg/mL syrup.

   Media release 18 January 2013 Pages: 3 - 3

8. The EMA confirms that Revlimid's [lenalidomide's] benefit-risk balance remains positive,

   Media release 18 January 2013 Pages: 3 - 3

9. EMA advises contraindications for terpenic-based antitussives

   Media release 18 January 2013 Pages: 3 - 3

10. Non-aspirin NSAIDs increase risk of renal cell cancer

    Clinical study 18 January 2013 Pages: 4 - 4

11. SAFERSleep system reduces anaesthesia drug errors

    Clinical study 18 January 2013 Pages: 4 - 4

12. Statins not associated with intracerebral haemorrhage

    Clinical study 18 January 2013 Pages: 4 - 4

13. COCs + obesity up hypertension risk in Chinese women

    Clinical study 18 January 2013 Pages: 4 - 4

14. Amiodarone

    Case report 18 January 2013 Pages: 5 - 5

15. Alteplase

    Case report 18 January 2013 Pages: 5 - 5

16. Amlodipine/rosuvastatin

    Case report 18 January 2013 Pages: 5 - 5

17. Amitriptyline overdose

    Case report 18 January 2013 Pages: 5 - 5

18. Amoxicillin

    Case report 18 January 2013 Pages: 6 - 6

19. Amoxicillin

    Case report 18 January 2013 Pages: 6 - 6

20. Amoxicillin/clavulanic acid

    Case report 18 January 2013 Pages: 6 - 7

21. Atazanavir/darunavir/ritonavir

    Case report 18 January 2013 Pages: 7 - 7

22. Anakinra

    Case report 18 January 2013 Pages: 7 - 7

23. Antineoplastics

    Case report 18 January 2013 Pages: 7 - 7

24. Antineoplastics

    Case report 18 January 2013 Pages: 7 - 7

25. Azathioprine/methylprednisolone/prednisolone

    Case report 18 January 2013 Pages: 9 - 9

26. BCG

    Case report 18 January 2013 Pages: 9 - 9

27. Baclofen

    Case report 18 January 2013 Pages: 9 - 9

28. Azathioprine/mercaptopurine/prednisone

    Case report 18 January 2013 Pages: 9 - 9

29. Bortezomib

    Case report 18 January 2013 Pages: 10 - 10

30. Cabergoline/ropinirole

    Case report 18 January 2013 Pages: 10 - 10

31. Bevacizumab

    Case report 18 January 2013 Pages: 10 - 10

32. Carboplatin

    Case report 18 January 2013 Pages: 11 - 11

33. Carboplatin/cisplatin

    Case report 18 January 2013 Pages: 11 - 11

34. Capecitabine/docetaxel

    Case report 18 January 2013 Pages: 11 - 11

35. Cisplatin/gemcitabine

    Case report 18 January 2013 Pages: 12 - 12

36. Cetuximab

    Case report 18 January 2013 Pages: 12 - 12

37. Cisplatin

    Case report 18 January 2013 Pages: 12 - 12

38. Cefazolin

    Case report 18 January 2013 Pages: 12 - 12

39. Cefotaxime

    Case report 18 January 2013 Pages: 12 - 12

40. Clomipramine

    Case report 18 January 2013 Pages: 13 - 13

41. Cisplatin/S-1

    Case report 18 January 2013 Pages: 13 - 13

42. Clomipramine

    Case report 18 January 2013 Pages: 13 - 13

43. Clozapine/caffeine/valproic acid interaction

    Case report 18 January 2013 Pages: 13 - 13

44. Clofazimine

    Case report 18 January 2013 Pages: 13 - 13

45. Cotrimoxazole

    Case report 18 January 2013 Pages: 14 - 14

46. Dalteparin sodium

    Case report 18 January 2013 Pages: 14 - 14

47. Cytarabine/daunorubicin

    Case report 18 January 2013 Pages: 14 - 14

48. Dasatinib/imatinib/nilotinib

    Case report 18 January 2013 Pages: 14 - 14

49. Cyclophosphamide/docetaxel

    Case report 18 January 2013 Pages: 14 - 14

50. Dienogest

    Case report 18 January 2013 Pages: 15 - 15